
Predictive Biomarkers of Response to Neoadjuvant I...
Melanoma is a deadly form of skin cancer, and while new immunotherapy treatments have significantly improved survival, not all patients respond the same way. Doctors curren...
Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Melanoma is a deadly form of skin cancer, and while new immunotherapy treatments have significantly improved survival, not all patients respond the same way. Doctors curren...
Melanoma is a disease that places an incredible physical, financial, and emotional burden upon our society. Treatment options for melanoma have been focused on targeting ou...
Melanoma is a deadly form of skin cancer, and while new immunotherapy treatments have significantly improved survival, not all patients respond the same way. Doctors curren...
Sinonasal mucosal melanoma (SNMM) is a rare high-grade malignancy involving the sinonasal tract, primarily including the nasal cavity, turbinates, nasopharynx, and paranasa...
Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactorial but include difficulty obtai...
Description: Mucosal melanoma (MM) is a rare form of melanoma with poor survival outcomes. Data on treatment for MM is limited to results from studies on cutaneous melanoma...
Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...
Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...
The Susan Fazio Melanoma Research Foundation Award
Jul 15, 2025 ET
Jul 22, 2025 ET